【レポートの概要（一部）】
Table of Contents
Chapter 1 Research Methodology
1.1 Information Procurement
1.2 Data Analysis
Chapter 2 Executive Summary
Chapter 3 Predictive Genetic Testing & Consumer/Wellness Genomics Market Variables, Trends & Scope
3.1 Market Segmentation & Scope
3.1.1 Market Driver Analysis
3.1.1.1 Rise in number of novel partnership models
3.1.1.2 Introduction of fragmented point-solutions across the genomics value chain
3.1.1.3 Exponentially decreasing costs for genetic sequencing
3.1.1.4 Introduction of technological advancements in cloud computing and data integration
3.1.2 Market Restraint Analysis
3.1.2.1 Absence of well-defined regulatory framework and low adoption rate
3.1.2.2 Ethical concerns pertaining to implementation
3.2 Penetration & Growth Prospect Mapping for Applications, 2015
3.3 Predictive genetic testing & consumer/wellness genomics-Swot Analysis, By Factor (Political & Legal, Economic And Technological)
3.4 Industry Analysis – Porter’s
Chapter 4 Predictive Genetic Testing & Consumer/Wellness Genomics Market: Test Type Estimates & Trend Analysis
4.1 Predictive Genetic Testing & Consumer/Wellness Genomics Market: Test Types Movement Analysis
4.2 Predictive Testing
4.2.1 Global predictive testing market, 2013 – 2025 (USD Million)
4.2.2 Genetic susceptibility test
4.2.2.1 Global genetic susceptibility test market, 2013 – 2025 (USD Million)
4.2.3 Predictive diagnostics
4.2.3.1 Global predictive diagnostics test market, 2013 – 2025 (USD Million)
4.2.4 Population screening programs
4.2.4.1 Global population screening programs market, 2013 – 2025 (USD Million)
4.3 Consumer Genomics
4.3.1 Global consumer genomics market, 2013 – 2025 (USD Million)
4.4 Wellness Genetics
4.4.1 Global wellness genetics market, 2013 – 2025 (USD Million)
4.4.2 Nutria Genetics
4.4.2.1 Global nutria genetics market, 2013 – 2025 (USD Million)
4.4.3 Skin & Metabolism Genetics
4.4.3.1 Global skin & metabolism genetics market, 2013 – 2025 (USD Million)
4.4.4 Others
4.4.4.1 Global others market, 2013 – 2025 (USD Million)
Chapter 5 Predictive Genetic Testing & Consumer/Wellness Genomics Market: Application Estimates & Trend Analysis
5.1 Predictive Genetic Testing & Consumer/Wellness Genomics Market: Application Movement Analysis
5.2 Breast & Ovarian Cancer Screening
5.2.1 Global breast & ovarian cancer screening market, 2013 – 2025 (USD Million)
5.3 Cardiovascular Screening
5.3.1 Global cardiovascular screening market, 2013 – 2025 (USD Million)
5.4 Diabetic Screening & Monitoring
5.4.1 Global diabetic screening & monitoring market, 2013 – 2025 (USD Million)
5.5 Colon Cancer Screening
5.5.1 Global colon cancer screening market, 2013 – 2025 (USD Million)
5.6 Parkinsonism / Alzheimer’s disease
5.6.1 Global Parkinsonism / Alzheimer’s disease market, 2013 – 2025 (USD Million)
5.7 Urologic Screening/ Prostate Cancer Screening
5.7.1 Global urologic screening/ prostate cancer screening market, 2013 – 2025 (USD Million)
5.8 Orthopedic & Musculoskeletal Screening
5.8.1 Global orthopedic & musculoskeletal screening market, 2013 – 2025 (USD Million)
5.9 Other Cancer Screening
5.9.1 Global other cancer screening market, 2013 – 2025 (USD Million)
5.10 Other Diseases Screening
5.10.2 Global other diseases screening market, 2013 – 2025 (USD Million)
Chapter 6 Predictive Genetic Testing & Consumer/Wellness Genomics Market: Regional Estimates & Trend Analysis, by Test Type & Application
6.1 Predictive Genetic Testing & Consumer/Wellness Genomics Market Share By Region, 2015 & 2025
6.2 North America
6.2.1 Predictive genetic testing & consumer/wellness genomics market, 2013 – 2025 (USD Million)
6.2.2 U.S.
6.2.2.1 Predictive genetic testing & consumer/wellness genomics market, 2013 – 2025 (USD Million)
6.2.3 Canada
6.2.3.1 Predictive genetic testing & consumer/wellness genomics market, 2013 – 2025 (USD Million)
6.3 Europe
6.3.1 Predictive genetic testing & consumer/wellness genomics market, 2013 – 2025 (USD Million)
6.3.2 Germany
6.3.2.1 Predictive genetic testing & consumer/wellness genomics market, 2013 – 2025 (USD Million)
6.3.3 UK
6.3.3.1 Predictive genetic testing & consumer/wellness genomics market, 2013 – 2025 (USD Million)
6.4 Asia Pacific
6.4.1 Predictive genetic testing & consumer/wellness genomics market, 2013 – 2025 (USD Million)
6.4.2 Japan
6.4.2.1 Predictive genetic testing & consumer/wellness genomics market, 2013 – 2025 (USD Million)
6.4.3 China
6.4.3.1 Predictive genetic testing & consumer/wellness genomics market, 2013 – 2025 (USD Million)
6.4.4 Australia
6.4.4.1 Predictive genetic testing & consumer/wellness genomics market, 2013 – 2025 (USD Million)
6.4.5 India
6.4.5.1 Predictive genetic testing & consumer/wellness genomics market, 2013 – 2025 (USD Million)
6.4.6 Singapore
6.4.6.1 Predictive genetic testing & consumer/wellness genomics market, 2013 – 2025 (USD Million)
6.5 Latin America
6.5.1 Predictive genetic testing & consumer/wellness genomics market, 2013 – 2025 (USD Million)
6.5.2 Brazil
6.5.2.1 Predictive genetic testing & consumer/wellness genomics market, 2013 – 2025 (USD Million)
6.6 MEA
6.6.1 Predictive genetic testing & consumer/wellness genomics market, 2013 – 2025 (USD Million)
6.6.2 South Africa
6.6.2.1 Predictive genetic testing & consumer/wellness genomics market, 2013 – 2025 (USD Million)
Chapter 7 Competitive Landscape
7.1 Strategy framework
7.2 Market participation categorization
7.2.1 Key Initiatives
7.3 Company Profiles
7.3.1 F. Hoffmann-La Roche Ltd
7.3.1.1 Company overview
7.3.1.1.1 454 Life Sciences (Roche Diagnostics Corporation)
7.3.1.2 Financial performance
7.3.1.3 Product benchmarking
7.3.1.4 Strategic initiatives
7.3.2 Abbott (Abbott Diagnostics)
7.3.2.1 Company overview
7.3.2.2 Financial performance
7.3.2.3 Product benchmarking
7.3.2.4 Strategic initiatives
7.3.3 Thermo Fisher Scientific, Inc.
7.3.3.1 Company overview
7.3.3.1.1 Affymetrix, Inc.
7.3.3.1.2 Applied Biosystems
7.3.3.2 Financial performance
7.3.3.2.1 Financial performance (Affymetrix)
7.3.3.3 Product benchmarking
7.3.3.4 Strategic initiatives
7.3.4 Agilent Technologies
7.3.4.1 Company overview
7.3.4.2 Financial performance
7.3.4.3 Product benchmarking
7.3.4.4 Strategic initiatives
7.3.5 BGI
7.3.5.1 Company overview
7.3.5.1.1 Complete Genomics Incorporated
7.3.5.2 Financial performance
7.3.5.3 Product benchmarking
7.3.5.4 Strategic initiatives
7.3.6 Bio-Rad Laboratories, Inc.
7.3.6.1 Company overview
7.3.6.1.1 GnuBIO, Inc.
7.3.6.2 Financial performance
7.3.6.3 Product benchmarking
7.3.6.4 Strategic initiatives
7.3.7 Illumina, Inc.
7.3.7.1 Company overview
7.3.7.2 Financial performance
7.3.7.3 Product benchmarking
7.3.7.4 Strategic initiatives
7.3.8 QIAGEN
7.3.8.1 Company overview
7.3.8.2 Financial performance
7.3.8.3 Product benchmarking
7.3.8.4 Strategic initiatives
7.3.9 Alere
7.3.9.1 Company overview
7.3.9.2 Financial performance
7.3.9.3 Product benchmarking
7.3.9.4 Strategic initiatives
7.3.10 Myriad Genetics, Inc.
7.3.10.1 Company overview
7.3.10.2 Financial performance
7.3.10.3 Product benchmarking
7.3.10.4 Strategic initiatives
7.3.11 Siemens Healthineers
7.3.11.1 Company overview
7.3.11.2 Financial performance
7.3.11.3 Product benchmarking
7.3.11.4 Strategic initiatives
7.3.12 Pathway Genomics
7.3.12.1 Company overview
7.3.12.2 Financial performance
7.3.12.3 Product benchmarking
7.3.12.4 Strategic initiatives
7.3.13 Cooper Surgical, Inc.
7.3.13.1 Company overview
7.3.13.1.1 Genesis Genetics
7.3.13.1.2 Reprogenetics
7.3.13.1.3 Financial performance
7.3.13.1.4 Financial performance
7.3.13.2 Product benchmarking
7.3.13.3 Strategic initiatives
7.3.14 Ambry Genetics Corporation
7.3.14.1 Company overview
7.3.14.2 Financial performance
7.3.14.3 Product benchmarking
7.3.14.4 Strategic initiatives
7.3.15 23andMe, Inc.
7.3.15.1 Company overview
7.3.15.2 Financial performance
7.3.15.3 Product benchmarking
7.3.15.4 Strategic initiatives
7.3.16 Danaher
7.3.16.1 Company overview
7.3.16.1.1 Beckman Coulter, Inc.
7.3.16.2 Financial performance
7.3.16.3 Product benchmarking
7.3.16.4 Strategic initiatives
7.3.17 Cepheid
7.3.17.1 Company overview
7.3.17.2 Financial performance
7.3.17.3 Product benchmarking
7.3.17.4 Strategic initiatives
7.3.18 Hologic, Inc. (Gen-Probe Incorporated)
7.3.18.1 Company overview
7.3.18.2 Financial performance
7.3.18.3 Product benchmarking
7.3.18.4 Strategic initiatives
7.3.19 ARUP Laboratories
7.3.19.1 Company overview
7.3.19.2 Financial performance
7.3.19.3 Product benchmarking
7.3.19.4 Strategic initiatives
7.3.20 GUARDANT HEALTH, INC
7.3.20.1 Company overview
7.3.20.2 Financial performance
7.3.20.3 Product benchmarking
7.3.20.4 Strategic initiatives
7.3.21 Advanced Genomic Solutions (AGS) Ltd
7.3.21.1 Company overview
7.3.21.2 Financial performance
7.3.21.3 Product benchmarking
7.3.21.4 Strategic initiatives
7.3.22 EasyDNA
7.3.22.1 Company overview
7.3.22.2 Financial performance
7.3.22.3 Product benchmarking
7.3.22.4 Strategic initiatives
7.3.23 Color Genomics, Inc.
7.3.23.1 Company overview
7.3.23.2 Financial performance
7.3.23.3 Product benchmarking
7.3.23.4 Strategic initiatives
7.3.24 Counsyl, Inc.
7.3.24.1 Company overview
7.3.24.2 Financial performance
7.3.24.3 Product benchmarking
7.3.24.4 Strategic initiatives
7.3.25 Gene by Gene
7.3.25.1 Company overview
7.3.25.2 Financial performance
7.3.25.3 Product benchmarking
7.3.26 Mapmygenome
7.3.26.1 Company overview
7.3.26.2 Financial performance
7.3.26.3 Product benchmarking
7.3.26.4 Strategic initiatives
7.3.27 Interleukin Genetics Inc.
7.3.27.1 Company overview
7.3.27.2 Financial performance
7.3.27.3 Product benchmarking
7.3.27.4 Strategic initiatives
7.3.28 Laboratory Corporation of America Holdings (LabCorp)
7.3.28.1 Company overview
7.3.28.2 Financial performance
7.3.28.3 Product benchmarking
7.3.28.4 Strategic initiatives
7.3.29 Quest Diagnostics Incorporated
7.3.29.1 Company overview
7.3.29.1.1 Sonora Quest Laboratories
7.3.29.2 Financial performance
7.3.29.2.1 Financial performance
7.3.29.3 Product benchmarking
7.3.29.4 Strategic initiatives
7.3.30 Xcode
7.3.30.1 Company overview
7.3.30.2 Financial performance
7.3.30.3 Product benchmarking
7.3.30.4 Strategic initiatives
7.3.31 Amgen, Inc.
7.3.31.1 Company overview
7.3.31.1.1 deCODE genetics
7.3.31.2 Financial performance (Amgen, Inc.)
7.3.31.3 Product benchmarking
【レポート販売概要】
■ タイトル：予測遺伝子検査と消費者/ウェルネスゲノミクスの世界市場分析：用途別（がん、糖尿病のスクリーニング、パーキンソン病、循環器、整形外科･筋骨格系、ヌートリア遺伝学、皮膚･代謝遺伝学）、動向分析、2013-2025■ 英文：Predictive Genetic Testing And Consumer/Wellness Genomics Market By Application (Cancer, Diabetic Screening, Parkinsonism, Cardiovascular, Orthopedic & Musculoskeletal, Nutria Genetics, Skin & Metabolism Genetics), And Trend Analysis From 2013 To 2025
■ 発行日：2017年1月27日
■ 調査会社：Grand View Research
■ 商品コード：GVIEW707698
■ 調査対象地域：グローバル
- 防腐剤・消毒剤の世界市場：種類別（第4級アンモニウム、塩素）、製品種類別（医療機器消毒剤）、最終用途別、セグメント予測The global antiseptics and disinfectants market size is expected to reach USD 27.99 billion by 2026, according to a new report by Grand View Research, Inc. It is anticipated to expand at a CAGR of 6.7% during the forecast period. Increasing prevalence of Hospital-acquired Infections (HAIs), awareness about home cleanliness and the need for disinfection, and usage of endoscope reprocesses and surgi …
- アメリカの宝くじ市場2016-2020About Lottery in the US Lottery is banned in various states in the US mainly due to its impacts on the society. The purchase of lottery can be addictive, hence impacting the livelihood of many. However, due to easier ROI, the demand for lottery has increased. Higher jackpot values have raised the demand for tickets with larger jackpot amount in state lotteries of the US. This lures casual players …
- ワクチンの世界市場2016-2020About Human Vaccine According to the Centers for Disease Control and Prevention (CDC), a vaccine is a product that stimulates a person’s immune system to produce immunity to a specific disease, protecting the person from that disease. Vaccines are usually administered through needle injections, but can also be administered by mouth or sprayed into the nose. Human vaccines are of two types: prevent …
- Coastal Energy Company：石油・ガスの開発・生産動向及びコスト分析- Q1, 2013Coastal Energy Company Oil & Gas Exploration and Production Operations and Cost Analysis - Q1, 2013 Summary Coastal Energy Company Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential sour …
- 装甲車両用自動消火システム（AFES）の世界市場2016-2020About Armored Vehicles Automatic Fire Extinguishing Systems In the defense sector, automatic fire extinguishing systems (AFES) are used in armored vehicles to protect the crew from hazards such as improvised explosive device (IED) threats and fuel explosions. They preserve the cabin and engine compartment of the vehicle with the help of sensors, which detects and suppresses fire using extinguishin …
- 世界の変圧器油市場Transformer oil is a dielectric fluid mainly used in oil filled electrical transformers as an insulating and cooling medium. It is usually obtained by fractional distillation and subsequent processing of crude oil. The primary purpose of transformer oil is to insulate and cool the transformer windings and core. These also preserve the core and winding as these are fully immersed in the oil and pre …
- スチレン・ブタジエンゴムの世界市場：E-SBR、S-SBRAbout SBR SBR is a synthetic rubber formed by the copolymerization of styrene and butadiene in the ratio of 3:1 by weight. SBR is manufactured through two different processes: emulsion and solution, to form emulsion-SBR and solution-SBR, respectively. It is used for various applications such as in the Tyre, Footwear, Polymer Modification, and Adhesive sectors. TechNavio's analysts forecast the Glo …
- ブローチ盤の世界市場2019-2023109 pages, November 2018 About this market Vendors are differentiating their products and services to remain competitive in this fragmented market. By integrating with automation vendors, broaching machine manufacturers are providing products such as automated broaching machines. Electromechanical broaching machines require strong an energy-efficient control system that provide optimum end-results …
- 高タンパク質食品の世界市場2017-2021About High Protein Based Food High-protein-based food products are specially-made products that help to build energy and muscle, and improve one's overall health. These products are also good sources of various fortified nutrients, including proteins, vitamins, minerals, carbohydrates, and fats. The concept of high-protein-based foods has gained worldwide popularity in the past few years. In the U …
- ニードルフリー（無針）ドラッグデリバリー製品の世界市場：ジェットインジェクター、経皮吸収パッチAbout Needle-free Drug Delivery Technology Needle-free drug delivery technologies are used to deliver drugs or vaccines into a patient’s body without the need for a traditional needle. The primary objectives of the development of these technologies are to eliminate NSI and its associated complications and increase patient compliance and comfort. Needle-free drug delivery systems include jet inject …
- アルゼンチンの発電市場2016：市場動向、制度、競争状況Argentina Power Market Outlook to 2030, Update 2016 - Market Trends, Regulations, and Competitive Landscape Summary This report elaborates Argentina's power market structure and provides historical and forecast numbers for generation, capacity and consumption up to 2030. Detailed analysis of the Argentina power market’s regulatory structure, import and export trends, competitive landscape, and pow …
- 過酢酸の世界市場：殺菌剤、清浄剤、滅菌剤The global peracetic acid market is estimated to reach USD 783.3 Million by 2020, registering a CAGR of 8.33% between 2015 and 2020. The market is driven by its unique properties such as delivery of optimum performance, emission of safe by-products, long shelf life, and slow thermal degradation. This is the prime factor responsible for the high demand of peracetic acid. Peracetic acid is used in v …
- Monoclonal Antibodies Market in Colorectal Cancer to 2019 – Favorable Pricing Policy in the US and Rising Prevalence in Europe and Japan Ensures Market GrowthMonoclonal Antibodies Market in Colorectal Cancer to 2019 - Favorable Pricing Policy in the US and Rising Prevalence in Europe and Japan Ensures Market Growth Summary GBI Research, has released the pharma report “Monoclonal Antibodies Market in Colorectal Cancer to 2019 - Favorable Pricing Policy in the US and Rising Prevalence in Europe and Japan Ensures Market Growth”. There are currently three …
- モバイルCDN（コンテンツデリバリネットワーク）の世界市場予測In the midst of intense competition, companies are striving for recurring businesses from existing customers. This helps them in anticipating revenue based on continuous transactions and in establishing more lucrative supplier–customer relationships. The growth in the adoption of mobile Content Delivery Network (CDN) solutions and services across various industries has created opportunities for co …
- ガスクロマトグラフィーの世界市場2017-2021About Gas Chromatograph Chromatography refers to a set of laboratory techniques used for the separation of mixtures. It involves a mobile phase and a stationary phase. The mixture is dissolved in the mobile phase, which is then passed to the stationary phase. The separation of the mixture is caused by the different speeds at which the various constituents of the mixture travel. The separation of t …
